These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31823668)

  • 1. Affimers as anti-idiotypic affinity reagents for pharmacokinetic analysis of biotherapeutics.
    Adamson H; Nicholl A; Tiede C; Tang AA; Davidson A; Curd H; Wignall A; Ford R; Nuttall J; McPherson MJ; Johnson M; Tomlinson DC
    Biotechniques; 2019 Dec; 67(6):261-269. PubMed ID: 31823668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing anti-idiotypic antibody alternatives to advance biotherapeutic pharmacokinetic assays.
    Johnson M
    Bioanalysis; 2020 Feb; 12(3):125-128. PubMed ID: 31975607
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.
    Tornetta M; Fisher D; O'Neil K; Geng D; Schantz A; Brigham-Burke M; Lombardo D; Fink D; Knight D; Sweet R; Tsui P
    J Immunol Methods; 2007 Dec; 328(1-2):34-44. PubMed ID: 17888945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of high-affinity, neutralizing anti-idiotype antibodies by phage and ribosome display for application in immunogenicity and pharmacokinetic analyses.
    Chin SE; Ferraro F; Groves M; Liang M; Vaughan TJ; Dobson CL
    J Immunol Methods; 2015 Jan; 416():49-58. PubMed ID: 25449532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation by phage display and characterization of drug-target complex-specific antibodies for pharmacokinetic analysis of biotherapeutics.
    Harth S; Ten Haaf A; Loew C; Frisch C; Knappik A
    MAbs; 2019 Jan; 11(1):178-190. PubMed ID: 30516449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Molecular Engineering of an Anti-Idiotypic Antibody for Pharmacokinetic Analysis of a Fully Human Anti-Infective.
    Lim SY; Chan CE; Lisowska MM; Hanson BJ; MacAry PA
    PLoS One; 2015; 10(12):e0145381. PubMed ID: 26700297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affimers as an alternative to antibodies for protein biomarker enrichment.
    Tans R; van Rijswijck DMH; Davidson A; Hannam R; Ricketts B; Tack CJ; Wessels HJCT; Gloerich J; van Gool AJ
    Protein Expr Purif; 2020 Oct; 174():105677. PubMed ID: 32461183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiotypic analysis of monoclonal anti-fluorescyl antibodies: localization and characterization of idiotypic determinants.
    Kranz DM; Voss EW
    Mol Immunol; 1983 Dec; 20(12):1301-12. PubMed ID: 6197634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses.
    Liu Z; Panousis C; Smyth FE; Murphy R; Wirth V; Cartwright G; Johns TG; Scott AM
    Hybrid Hybridomics; 2003 Aug; 22(4):219-28. PubMed ID: 14511567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific detection of myeloma plasma cells using anti-idiotypic single chain antibody fragments selected from a phage display library.
    Willems PM; Hoet RM; Huys EL; Raats JM; Mensink EJ; Raymakers RA
    Leukemia; 1998 Aug; 12(8):1295-302. PubMed ID: 9697887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative ELISA for T4 determination based on idiotype anti-idiotype interaction and a latex method for anti-idiotype monoclonal antibody selection.
    Becker MI; Aguayo JE; Jamett A; Juica F; Yudelevich A; Foradori A; De Ioannes AE
    J Immunol Methods; 1996 Jun; 192(1-2):73-85. PubMed ID: 8699024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and characterisation of Affimers specific for CEA recognition.
    Shamsuddin SH; Jayne DG; Tomlinson DC; McPherson MJ; Millner PA
    Sci Rep; 2021 Jan; 11(1):744. PubMed ID: 33436840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic immunoassay methods in the presence of soluble target.
    Verch T; Chilewski S; Bouaraphan S; Yarovoi H; Yin KC; Chen D; Washabaugh MW
    J Immunol Methods; 2010 Sep; 361(1-2):75-81. PubMed ID: 20696169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiotypic cross-reactivity of low-affinity anti-fluorescyl monoclonal antibodies.
    Reinitz DM; Voss EW
    Mol Immunol; 1984 Sep; 21(9):775-84. PubMed ID: 6434941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affimers as an Alternative to Antibodies in an Affinity LC-MS Assay for Quantification of the Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Human Serum.
    Klont F; Hadderingh M; Horvatovich P; Ten Hacken NHT; Bischoff R
    J Proteome Res; 2018 Aug; 17(8):2892-2899. PubMed ID: 30005571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective absorption of anti-DNA antibodies and their idiotype-positive cells in vitro using an anti-idiotypic antibody-affinity column: possible application to plasma exchange.
    Harata N; Sasaki T; Shibata S; Kameoka J; Hirabayashi Y; Osaki H; Tamate E; Yoshinaga K
    J Clin Apher; 1991; 6(1):34-9. PubMed ID: 2045381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-rate screening for selection of high-affinity anti-drug antibodies.
    Ylera F; Harth S; Waldherr D; Frisch C; Knappik A
    Anal Biochem; 2013 Oct; 441(2):208-13. PubMed ID: 23906643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of defined idiotypes throughout the BALB/c anti-fluorescyl antibody response: affinity and idiotype analyses of heterogeneous antibodies.
    Kranz DM; Ballard DW; Voss EW
    Mol Immunol; 1983 Dec; 20(12):1313-22. PubMed ID: 6197635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titration calorimetry study of an anti-idiotypic antibody cascade in a human melanoma-associated antigen system.
    Mutz M; Hawthorne T; Ferrone S; Pluschke G
    Mol Immunol; 1997 Jul; 34(10):695-707. PubMed ID: 9430197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-idiotype antibody-dependent cell-mediated cytotoxicity (ADCC) against idiotype-bearing cells.
    Caraux J; Weigle WO
    Cell Immunol; 1983 May; 78(1):23-32. PubMed ID: 6602001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.